Bulging order book for bioconjugates lifts WuXi XDC profits
The provider of outsourced pharmaceutical services has delivered unexpectedly strong half-year earnings and has launched its first overseas production hub Key Takeaways: WuXi XDC began operations in August at a…
WuXi AppTec sues to get its name removed from U.S. blacklist
Pharmaceutical services provider WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) has sued the U.S. Defense Department, seeking to have its name removed from the department’s list of Chinese companies with military…
WuXi AppTec wages buyback campaign as U.S. pressure mounts
The drug services provider has been battling to shore up its share price and suffered a sharp sell-off after being added to a U.S. list of firms with suspected military…
China’s corporate pivots: Alibaba’s food delivery gambit and WuXi AppTec’s geopolitical hedge
Alibaba will retire the Ele.me takeout dining brand and merge it with its newer Taobao Instant Commerce. What's driving the move? And WuXi AppTec is the latest Chinese major to jump on the Middle Eastern bandwagon, with plans to potentially open a new center in Saudi Arabia. Why are a growing number of Chinese companies taking the Middle Eastern plunge?
WuXi AppTec frees up money for Middle East push
The drugs services giant has stepped up sales of non-core Chinese assets to concentrate on its international expansion, with plans for a base in Saudi Arabia Key Takeaways: The company…
BRIEF: WuXi AppTec raises $975 Million through share placement at 6.9% discount
Pharmaceutical outsourcing giant WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) announced on Thursday it will raise HK$7.65 billion ($975 million) by placing around 73.8 million new Hong Kong-listed shares at HK$104.27…
Fortune smiles again on WuXi AppTec with profit surge
The drug services giant has forecast a jump in revenue for the first half and a doubling of net profit, after U.S. policy concerns abated Key Takeaways: The projected results…
Recent Articles
WuXi AppTec sues to get its name removed from U.S. blacklist
2359.HK
603259.SHG
WuXi AppTec wages buyback campaign as U.S. pressure mounts
2359.HK
603259.SHG
WuXi AppTec frees up money for Middle East push
2359.HK
603259.SHG
Fortune smiles again on WuXi AppTec with profit surge
2359.HK
603259.SHG
